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Transthoracic esophagectomy (TTE) and transhiatal esophagectomy (THE) are two common methods of
resection for esophageal cancer. Although many studies have been performed in Western countries, there
are still controversies over which method is the better procedure. In this study, postoperative improvement
in dysphagia and the degree of postoperative pain were compared. The cases of 50 patients undergoing
TTE and 23 undergoing THE for esophageal cancer between March 1997 and October 2002 were
retrospectively reviewed. The location of the lesion, clinical stage (TNM), operative time, operative blood
loss, hospital stay, complications, number of lymph nodes dissected, and survival duration were recorded.
Pre- and postoperative dysphagia scores and postoperative pain perception (using a visual analog scale)
were analyzed. Preoperative clinical stage and lesion site were not significantly different in the TTE and
THE groups. The operative time was longer and the number of lymph nodes removed was larger in the
TTE group. However, there were no differences in operative blood loss, hospital stay, complications,
survival duration, and improvement in dysphagia. Pain perception in the THE group was significantly
better than that in the TTE group. THE is a safe and rapid procedure, with recovery and survival periods
similar to those for TTE. Both patient groups enjoyed the same ability to eat. Therefore, THE is an acceptable
alternative to TTE for patients with middle- and lower-third esophageal cancer. Moreover, THE caused
much less postoperative pain than TTE, which made patients more comfortable.
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Esophageal cancer is a disease with a poor prognosis [1,2].
The outcome is largely poor despite the greatest surgical
efforts. Although the results of surgery are not good, com-
plete esophagectomy remains the mainstream treatment
as it offers the best opportunity for cure or palliation [3,4].
There are two common methods of esophagectomy,
namely transthoracic (TTE) and transhiatal (THE). Torek
successfully resected an esophageal carcinoma using the
transthoracic approach in 1913 [2]. After that, esophagectomy
through a right side thoracotomy was advocated by some
authors [5]. It allows for a wide operative field for mediasti-
nal lymphadenectomy and direct control of bleeding [6].
THE was first performed by Turner [7] and later advocat-
ed by Orringer [8]. It has the advantages of not requiring
thoracotomy and having a lower incidence of pulmonary
complications [9] and a shorter operative time [10]. Although
some authors have reported no difference compared with
TTE [11,12], others have shown a higher rate of respiratory
complications [4,13]. Most studies have examined lower-
third lesions; studies in Asian people are few. In this study,
we compared pre- and postoperative dysphagia scores [14]
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and postoperative pain perception using a visual analog
scale (VAS) [15], which are lacking in other studies.
MATERIALS AND METHODS
Between March 1997 and October 2002, 50 patients un-
derwent TTE and 23 patients underwent THE in Kaohsiung
Medical University Hospital. In this study, their cases were
retrospectively reviewed. Operative time, intraoperative
blood loss, postoperative hospital stay, complications,
number of lymph nodes removed, and survival duration
were recorded. The dysphagia score was recorded pre-
operatively and at 1, 3, 6, and 12 months postoperatively.
The VAS for pain perception was recorded postoperatively
at 1 week and 1, 3, and 6 months. Preoperative studies to
confirm resectability included esophagogram, ultrasound
endoscopy, and chest computerized tomography (CT). The
diagnosis was confirmed by biopsy. Bronchoscopy was
indicated for middle-third cancers. All patients received
pulmonary physiotherapy using incentive spirometry and
pulmonary inhalation of mucolytics for bronchial toilet at
least 7 days before the operation.
Transthoracic approach
The patient was placed in the supine position with the
head turned towards the right and neck extended. After
laparotomy, the stomach was mobilized by dividing the
greater omentum while preserving the right gastroepiploic
vessels. The short gastric vessels were also divided. The
esophagogastric junction was freed from the hiatus. The
lesser omentum and the gastrohepatic ligament were
then divided. The left gastric artery was carefully ligated
and divided. All celiac lymph nodes were simultaneously
dissected. The abdominal esophagus was transected and
both ends sutured securely. The proximal end was then
pushed upward into the mediastinum and the hiatus was
closed with non-absorbable stitches. After Kocher’s maneu-
ver and pyloromyotomy, the esophagogastric junction
and part of the lesser curvature were resected using a
curved Akiyama Petz autosuture.
A left cervical incision was made along the anterior
border of the left sternocleidomastoid muscle and dissec-
tion was carried out along the prevertebral space. When
the cervical esophagus was found, blunt dissection was per-
formed down to the level of the thoracic outlet. The esopha-
gus was transected and the distal stump was securely su-
tured. A retrosternal tunnel was created and the stomach
was passed up through this tunnel into the neck. Cervical
esophagogastrostomy was performed by hand-sewn single
mattress anastomosis.
The patient was then repositioned for right thoracotomy.
The mediastinal pleura was incised. Both cut ends of the
esophagus were found and dissected towards the tumor.
The tumor and adjacent tissues were totally removed.
Mediastinal lymph nodes were then dissected for sampling.
Transhiatal approach
The patient was positioned and the stomach mobilized
as in TTE, but there was no transection of the abdominal
esophagus. The cervical phase was also performed as for
TTE, but with no transection of the esophagus. With the left
hand inserted through the cervical wound and the right
hand through the diaphragmatic hiatus, blunt dissection
was carried out along the esophagus until the entire organ
was mobilized. Several centimeters of esophagus were gent-
ly pulled up into the cervical region and then transected.
The distal stump was carefully closed and the stomach and
esophagus (with tumor) were then removed through the
diaphragmatic hiatus. Using a curved Akiyama Petz auto-
suture, the esophagus, cardia, and an area along the lesser
curvature were resected. The stomach was delivered to the
neck wound through the retrosternal tunnel. Again, cervical
esophagogastrostomy was performed as for TTE.
Postoperative period
Feeding jejunostomy was routine for both TTE and THE
patients. Patients were transferred to the intensive care
unit postoperatively. Total parenteral nutrition was ad-
ministered. Patients were weaned off the ventilator and
were sent back to the ward as soon as possible. Jejunostomy
feeding was administered if there was bowel movement. If
there was no anastomotic leakage, oral intake was given on
the 10th day. Postoperative pain was relieved by patient-
controlled analgesia using intravenous morphine for the
first 3 days. Patients were followed up regularly in the
outpatient clinic, and radiotherapy was administered for
gross or microscopic residual tumor.
Statistical analysis
The age, sex, lesion location, and clinical stage were ana-
lyzed using the Chi-squared test. The operative time, intra-
operative blood loss, postoperative hospital stay, and num-
ber of lymph nodes dissected were compared using Stu-
dent’s t test. Postoperative complications were compared
using Fisher’s exact test, the dysphagia score and VAS
using repeated ANOVA, and survival using the log-rank
test.
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RESULTS
The number of patients, age, sex ratio, lesion location, and
clinical stage in the two groups were similar (Table 1). The
mean operative time for TTE was significantly longer than
that for THE (Table 2). The mean intraoperative blood loss
and mean postoperative hospital stay were not significantly
different. Significantly more lymph nodes were dissected
in the TTE group (Table 2). There were two 30-day mortalities
in each group. In the TTE group, five patients (10%) had
pneumonia, three (6%) had gastrointestinal bleeding,
and five (10%) had anastomotic leakage. In the THE group,
three patients (13%) had pneumonia, two (8.7%) had
gastrointestinal bleeding, three (13%) had anastomotic
leakage, and one (4.3%) had cardiac arrhythmia. There
was no significant difference in complications between
the two groups (p > 0.05).
No tracheal tear and no conversion were recorded in the
THE group. All the proximal and distal margins were free
of tumor. Mean preoperative dysphagia score in the TTE
group was 3.10 ± 0.47. Mean postoperative score at 1 month
was 2.29 ± 0.58, at 3 months was 1.63 ± 0.61, at 6 months was
1.14 ± 0.64, and at 12 months was 0.92 ± 0.59; the decrease
in score was significant (p < 0.001). In the THE group, the
respective pre- and postoperative scores were 3.09 ± 0.54,
2.62 ± 0.5, 1.71 ± 0.64, 0.78 ± 0.65, and 0.43 ± 0.51; again, the
decrease was significant (p < 0.001). The degree of decrease
in score was similar in the two groups (p = 0.336) (Figure 1).
In the TTE group, mean VAS at 1 week and 1, 3, and 6
months was 8.10 ± 0.78, 6.08 ± 1.05, 3.85 ± 0.92, and 2.28 ±
0.91, respectively. In the THE group, these scores were
6.67 ± 1.02, 3.05 ± 0.92, 0.71 ± 0.64, and 0.31 ± 0.48, respectively
(Figure 2). The score in both groups decreased significantly
(p < 0.001). Moreover, the VAS was significantly lower in the
THE group than in the TTE group (p < 0.001). The 2-year
survival rate in the two groups was not significantly different
(TTE: 28% vs THE: 39.5%; p = 0.295) (Figure 3). There was
no significant difference in survival rates between patients
with middle- and lower-third lesions in the THE group.
DISCUSSION
In 2000, 890 patients died of esophageal cancer in Taiwan
(population 23 million) [16]. The expected 5-year survival
rate is only 5–12% [17]. The treatment of esophageal cancer
remains a great challenge to surgeons. Few reports have
compared TTE and THE for middle-third lesions in Asians.
Even in recent reports, only lower-third lesions were com-
Table 2. Comparison of operative results for transthoracic
(TTE) and transhiatal (THE) esophagectomy
TTE (n = 50) THE (n = 23)
Operative time (min)* 373.4 ±  94.5   265.5 ±  49.3
Intraoperative blood loss (mL) 354.5 ±  217.4  377.2 ±  251.6
Postoperative hospital stay (d) 20.7 ±  17.4 18.6 ±  13.7
Number of lymph nodes 9.3 ±  2.7 5.3 ±  1.9
removed*
*Student’s t test, p < 0.05.
Table 1. Demographic data of transthoracic (TTE) and
transhiatal (THE) esophagectomy groups
TTE (n = 50) THE (n = 23)
Age (yr) 52.6 ±  10.6 57.4 ±  12.4
Sex (male:female) 46:4 21:2
Location of lesion
  Middle third 42 17
  Lower third 8 6
Clinical stage according to TNM
  II 11 5
  III 39 18
Chi-squared test, p > 0.05.
Figure 1. Comparison of improvement in dysphagia between transthoracic
(TTE) and transhiatal (THE) esophagectomy groups, using repeated
ANOVA.
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pared [3,4,18]. This study included mostly lesions in the
middle third.
There was no difference in age, sex, lesion location, and
clinical stage between the two treatment groups. Post-
operative stay, intraoperative blood loss, and complications
were also similar in the two groups. The only significant
difference was that the operative time was shorter in the
THE group.
One important reason for proposing TTE is that the
complete mediastinal node dissection provides a survival
benefit [5,6]. However, more and more surgeons have
reported that there is no significant difference in survival
between the two procedures [10,13]. A possible explanation
would be that lesions in those studies were mainly in the
lower third: in these studies, transhiatal dissection of lower-
third tumors was done under direct vision and lymph node
dissections were performed as in TTE. In our series, 80.8%
of tumors were in the middle third. The number of lymph
nodes dissected in THE, which could not be performed
under direct vision, was less than that in TTE (p < 0.001).
However, there was no difference in survival between the
two groups (Figure 3). This may be due to the comparable
number of involved nodes in the two groups. Some authors
have reported that survival is influenced more by disease
stage than the type of operation performed [10,19]. Radical
mediastinectomy may only have value in the treatment of
T1 cancers. THE is advocated by many authors as being
more useful in lower-third cancers because the tumor can
easily be dissected under direct vision [3,20]. Wong even
considers middle-third lesions a contraindication for THE
[21]. Orringer et al reported a 5-year survival rate of 32% for
lower-third and 18% for middle-third esophageal cancer in
1993 [22], which had decreased to 26% for lower-third and
13% for middle-third tumors by 1999 [19]. It is obvious that
middle-third lesions are still associated with worse survi-
val. In our series, survival rates with THE for middle- and
lower-third tumors were not significantly different (log-
rank test). Barbier et al reported that THE was the treatment
of choice for esophageal carcinoma at all levels [23], and we
have not had any difficulty in dissecting a middle-third
tumor through the hiatus because our patients were fully
assessed and carefully staged preoperatively by our can-
cer team and treated according to our treatment guide-
lines for esophageal carcinoma. This made the results of
THE, even in middle-third cancers, better than expected.
Although the present series is a retrospective study, the
preoperative clinical stage was not significantly different
between the two groups. That is to say, there was no bias to
assign less-advanced cases to transhiatal resection. In
fact, THE can be applied to all patients who require esoph-
agectomy for cancer except those with tracheobronchial
invasion, fixation of tumor to the aorta, or dense adherence
to the surrounding mediastinal organs due to previous
inflammation or irradiation. In simpler words, THE should
be converted to TTE only if the surgeon feels unsafe during
the dissection.
The new information in this paper is the comparison of
two basic subjective feelings, the degree of dysphagia and
pain perception, which were missing in past studies. They
affect daily quality of life. Although they do not completely
reflect the quality of life, the improvement in swallowing
and severity of postoperative pain are of most concern to
Figure 2. Comparison of improvement in visual analog scale score
between transthoracic (TTE) and transhiatal (THE) esophagectomy
groups, using repeated ANOVA.
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patients with dysphagia who undergo surgery, and dys-
phagia score and VAS are the best systems to measure
these symptoms. In this study, preoperative dysphagia
score was similar in the two groups and improved signi-
ficantly by the same degree postoperatively. However,
for pain perception, the VAS in the TTE group was 8.10 ±
0.78 and that in the THE group was 6.67 ±  1.02 in the
immediate postoperative period. At 1 month, the VAS in
the THE group dropped to 3.05 ±  0.92, but remained at
6.08 ± 1.05 in the TTE group, which was significantly dif-
ferent. At 3 months, there was almost no pain in the THE
group. On the contrary, the VAS at 6 months was 2.28 ±
0.91 in the TTE group. That is to say, TTE caused chronic
pain and annoyance for up to 6 months in some people.
In conclusion, THE is a safe procedure and faster than
TTE, with recovery and survival comparable to those with
TTE. Both groups had the same degree of improvement
in dysphagia. Therefore, THE is an acceptable alternative
procedure to TTE for middle- and lower-third esophageal
cancers. Moreover, THE caused much less postoperative
pain than TTE, making patients more comfortable.
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